Concepedia

Mo Xiao

MX

8

Publications

310

Citations

8

H-Index

2017

Active since

Affiliations

Nanjing Medical University(Current)

Jiangsu Cancer Hospital

Wannan Medical College

Shandong University

First Affiliated Hospital of Wannan Medical College

Mo Xiao is an author at Nanjing Medical University specializing in medicine, cell biology, and cancer research.

Top concepts

Publications per year

2017–2022

8

Publications

8

Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver

Tao Zeng, Cuili Zhang, Ning Zhao et al. · Redox Biology · 2017 · 109 citations · Full text

, , +22

S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways

Dan Fang, Chengfei Zhang, Ping Xu et al. · Cell Biology and Toxicology · 2021 · 52 citations

, , +9

STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway

Chengfei Zhang, Xiaoming Wang, Dan Fang et al. · Theranostics · 2020 · 42 citations · Full text

KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma

Mo Xiao, Chengfei Zhang, Ping Xu et al. · Acta Pharmacologica Sinica · 2021 · 39 citations · Full text

, , +9

Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer

Hongjin Chen, Xiaoming Wang, Fubing Wu et al. · Genomics · 2020 · 23 citations

, , +12

Rows per page

1–5 of 8